Tailored, psychological intervention for anxiety or depression in people with chronic obstructive pulmonary disease (COPD), TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD): protocol for a randomised controlled trial.
Anxiety
COPD
Clinical effectiveness
Co-morbidity
Cognitive behavioural approach
Complex intervention
Depression
Health economic evaluation
Pragmatic randomised controlled trial
Pulmonary rehabilitation
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
06 Jan 2020
06 Jan 2020
Historique:
received:
25
07
2019
accepted:
11
10
2019
entrez:
8
1
2020
pubmed:
8
1
2020
medline:
18
11
2020
Statut:
epublish
Résumé
People with chronic obstructive pulmonary disease (COPD) are at increased risk of depression and anxiety, which greatly reduces their quality of life and is associated with worse outcomes; but these psychological co-morbidities are under-recognised and undertreated in COPD patients. Pulmonary rehabilitation (PR) improves mood for up to 6 months but health practitioners under-refer, and patients commonly fail to attend/complete PR. Research suggests that complex non-pharmacological interventions, including both psychological and exercise components, may reduce anxiety and depression in COPD. We have developed a tailored, cognitive behavioural approach (CBA) intervention for patients with COPD and co-morbid anxiety and/or depression ('TANDEM'), which precedes and optimises the benefits of currently offered PR. We hypothesise that such a psychological intervention, delivered by supervised, trained respiratory healthcare professionals, will improve mood in patients with mild to moderate anxiety and/or depression and encourage uptake and completion of PR. We will conduct a multi-centre, pragmatic, randomised controlled trial of the TANDEM intervention compared to usual care across the Midlands, London, the South East and Bristol, UK. We will train healthcare professionals familiar with COPD to deliver the manualised, tailored, face-to-face, one-to-one intervention weekly for 6-8 weeks. We will recruit 430 participants from primary, community and secondary care with confirmed COPD and moderate to very severe airflow limitation, who are eligible for assessment for PR, and who screen positive for symptoms of mild/moderate depression and/or anxiety using the Hospital Anxiety and Depression scale (HADS). Participants will be randomised 1.25:1 (intervention: usual care). The co-primary outcomes are the HADS anxiety and depression subscale scores at 6 months; participants will be followed up to 12 months. Secondary outcomes include uptake and completion of PR and healthcare resource use. There will be a parallel process evaluation and a health economic evaluation. The TANDEM intervention has the potential to optimise the unrealised synergy between a psychological intervention and PR. The CBA sessions will precede PR and target individuals' cognitions, behaviours and symptoms associated with anxiety and depression to decrease psychological morbidity and increase effective self-management amongst patients with COPD. ISRCTN, ID: ISRCTN59537391. Registered on 20 March 2017. Protocol version 6.0, 22 April 2018.
Sections du résumé
BACKGROUND
BACKGROUND
People with chronic obstructive pulmonary disease (COPD) are at increased risk of depression and anxiety, which greatly reduces their quality of life and is associated with worse outcomes; but these psychological co-morbidities are under-recognised and undertreated in COPD patients. Pulmonary rehabilitation (PR) improves mood for up to 6 months but health practitioners under-refer, and patients commonly fail to attend/complete PR. Research suggests that complex non-pharmacological interventions, including both psychological and exercise components, may reduce anxiety and depression in COPD. We have developed a tailored, cognitive behavioural approach (CBA) intervention for patients with COPD and co-morbid anxiety and/or depression ('TANDEM'), which precedes and optimises the benefits of currently offered PR. We hypothesise that such a psychological intervention, delivered by supervised, trained respiratory healthcare professionals, will improve mood in patients with mild to moderate anxiety and/or depression and encourage uptake and completion of PR.
METHODS
METHODS
We will conduct a multi-centre, pragmatic, randomised controlled trial of the TANDEM intervention compared to usual care across the Midlands, London, the South East and Bristol, UK. We will train healthcare professionals familiar with COPD to deliver the manualised, tailored, face-to-face, one-to-one intervention weekly for 6-8 weeks. We will recruit 430 participants from primary, community and secondary care with confirmed COPD and moderate to very severe airflow limitation, who are eligible for assessment for PR, and who screen positive for symptoms of mild/moderate depression and/or anxiety using the Hospital Anxiety and Depression scale (HADS). Participants will be randomised 1.25:1 (intervention: usual care). The co-primary outcomes are the HADS anxiety and depression subscale scores at 6 months; participants will be followed up to 12 months. Secondary outcomes include uptake and completion of PR and healthcare resource use. There will be a parallel process evaluation and a health economic evaluation.
DISCUSSION
CONCLUSIONS
The TANDEM intervention has the potential to optimise the unrealised synergy between a psychological intervention and PR. The CBA sessions will precede PR and target individuals' cognitions, behaviours and symptoms associated with anxiety and depression to decrease psychological morbidity and increase effective self-management amongst patients with COPD.
TRIAL REGISTRATION
BACKGROUND
ISRCTN, ID: ISRCTN59537391. Registered on 20 March 2017. Protocol version 6.0, 22 April 2018.
Identifiants
pubmed: 31907074
doi: 10.1186/s13063-019-3800-y
pii: 10.1186/s13063-019-3800-y
pmc: PMC6945421
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
18Subventions
Organisme : Department of Health
ID : CAT CDRF 10-023
Pays : United Kingdom
Organisme : Department of Health
ID : HTA/13/146/02
Pays : United Kingdom
Organisme : Health Technology Assessment Programme
ID : HTA Project: 13/146/02
Références
PLoS One. 2013 Apr 05;8(4):e60532
pubmed: 23585837
Chest. 2008 Oct;134(4 Suppl):43S-56S
pubmed: 18842932
Scand J Caring Sci. 2014 Jun;28(2):413-20
pubmed: 23713548
Br J Psychiatry. 2017 Jan;210(1):47-53
pubmed: 27856421
Eur Respir J. 2005 Sep;26(3):414-9
pubmed: 16135721
Lancet. 2012 Dec 15;380(9859):2163-96
pubmed: 23245607
Patient Educ Couns. 2007 May;66(2):192-201
pubmed: 17320338
J Glob Health. 2015 Dec;5(2):020415
pubmed: 26755942
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Health Econ. 2005 May;14(5):487-96
pubmed: 15497198
J Psychosom Res. 2007 Nov;63(5):551-65
pubmed: 17980230
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
Health Qual Life Outcomes. 2012 Dec 27;10:156
pubmed: 23270465
Implement Sci. 2018 Jun 7;13(1):80
pubmed: 29879986
Int J Chron Obstruct Pulmon Dis. 2010 Oct 05;5:319-26
pubmed: 21037955
Patient Educ Couns. 2011 Apr;83(1):29-36
pubmed: 20447795
Health Soc Care Community. 2017 Jan;25(1):11-25
pubmed: 26499310
Palliat Med. 2004 Oct;18(7):619-25
pubmed: 15540670
Lancet. 2012 Dec 15;380(9859):2095-128
pubmed: 23245604
Health Psychol. 2001 Mar;20(2):112-9
pubmed: 11315728
Gerontologist. 1980 Dec;20(6):649-55
pubmed: 7203086
Am J Respir Crit Care Med. 2012 May 1;185(9):918-23
pubmed: 22246177
Chron Respir Dis. 2014 May;11(2):95-102
pubmed: 24659210
Cochrane Database Syst Rev. 2015 Feb 23;(2):CD003793
pubmed: 25705944
J Psychosom Res. 2006 Jun;60(6):631-7
pubmed: 16731240
J Public Health Dent. 2011 Winter;71 Suppl 1:S52-63
pubmed: 21656954
Eur Respir J. 2014 Dec;44(6):1538-47
pubmed: 25186259
Am J Respir Crit Care Med. 1998 Oct;158(4):1185-9
pubmed: 9769280
Arch Intern Med. 2007 Nov 26;167(21):2345-53
pubmed: 18039994
J Psychosom Res. 2012 Nov;73(5):334-42
pubmed: 23062805
BMJ Open. 2013 Nov 15;3(11):e003555
pubmed: 24240140
Respirology. 2012 May;17(4):627-38
pubmed: 22309179
BMC Med. 2010 Oct 20;8:63
pubmed: 20961442
Health Technol Assess. 2015 Sep;19(73):1-124
pubmed: 26379122
Eur Clin Respir J. 2017 Jan 1;4(1):1332931
pubmed: 28649311
BMJ Open Respir Res. 2014 Nov 03;1(1):e000042
pubmed: 25478188
J Consult Clin Psychol. 2005 Oct;73(5):852-60
pubmed: 16287385
Ann Behav Med. 2009 Oct;38(2):86-93
pubmed: 19513800
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Int J Geriatr Psychiatry. 2010 Dec;25(12):1209-21
pubmed: 20033905
Br J Psychiatry. 2016 Jul;209(1):54-61
pubmed: 27151073
Trials. 2015 Sep 10;16:405
pubmed: 26357929
Palliat Med. 2006 Sep;20(6):579-84
pubmed: 17060250
ERJ Open Res. 2018 Nov 23;4(4):
pubmed: 30479999
Psychol Health Med. 2010 Aug;15(4):371-85
pubmed: 20677076
Clinicoecon Outcomes Res. 2013 Jun 17;5:235-45
pubmed: 23818799
Eur Respir J. 2013 Apr;41(4):815-23
pubmed: 22878874
Respir Med. 2011 Jan;105(1):57-66
pubmed: 20932736
BMC Pulm Med. 2013 Nov 04;13:62
pubmed: 24498939
Arch Intern Med. 2007 Jan 8;167(1):60-7
pubmed: 17210879
Respir Med. 2010 Jul;104(7):986-94
pubmed: 20346640
Thorax. 2010 Mar;65(3):229-34
pubmed: 20335292